Acutus Medical to Announce Second Quarter 2020 Financial Results

Rhea-AI Summary

Acutus Medical (Nasdaq: AFIB) will release its Q2 2020 financial results on September 17, 2020, post-market. A conference call and webcast are scheduled for 1:30 p.m. PT (4:30 p.m. ET) to discuss these results and recent highlights. Interested parties can join the call at (833) 570-1131 (domestic) or (914) 987-7078 (international) using conference ID: 9767216. The event will also be available for replay on the company's website for two weeks.

CARLSBAD, Calif., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), today announced it will release its financial results for the second quarter of 2020 after market close on Thursday, September 17, 2020. In conjunction with the release, Acutus will host a conference call and webcast at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to discuss its financial results and recent highlights.

Interested parties may access the live call via telephone by dialing (833) 570-1131 for domestic callers or (914) 987-7078 for international callers, using conference ID: 9767216. The live webinar of the call may be accessed by visiting the Events section of the Acutus website at ir.acutusmedical.com. A replay of the webinar will be available shortly after the conclusion of the call and will be archived on the company’s website for two weeks following the earnings call.

About Acutus Medical, Inc.
Acutus Medical is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. Acutus is committed to advancing the field of electrophysiology with a unique array of products and technologies which will enable more physicians to treat more patients more efficiently and effectively. Through internal product development, acquisitions and global partnerships, Acutus has established a global sales presence delivering a broad portfolio of highly differentiated electrophysiology products that provide its customers with a complete solution for catheter-based treatment of cardiac arrhythmias. Founded in 2011, Acutus is based in Carlsbad, California.

Investor Contact:
Caroline Corner
Westwicke ICR
D: 415-314-1725
Caroline.corner@westwicke.com

Holly Windler
M: 619-929-1275
media@acutusmedical.com

 

FAQ

When will Acutus Medical release its Q2 2020 financial results?

Acutus Medical will release its Q2 2020 financial results after market close on September 17, 2020.

What time is the conference call for Acutus Medical's Q2 results?

The conference call for Acutus Medical's Q2 results is scheduled for 1:30 p.m. Pacific Time on September 17, 2020.

How can I access the conference call for Acutus Medical?

You can access the conference call by dialing (833) 570-1131 for domestic callers or (914) 987-7078 for international callers, using conference ID: 9767216.

Is there a way to access a replay of Acutus Medical's conference call?

Yes, a replay of Acutus Medical's conference call will be available on their website for two weeks following the call.

What does Acutus Medical specialize in?

Acutus Medical specializes in arrhythmia management, focusing on improving how cardiac arrhythmias are diagnosed and treated.